Request a Personal Orientation

Avoiding Cancer ‘Overtreatment’

Avoiding-Cancer-'OvertreatmIn recent years, mammography and some other cancer screening tests have come under fire from those who claim the medical industry is prone to cancer “overtreatment.” The result, some say, is that U.S. women who find tiny breast cancers then undergo invasive treatments such as chemotherapy for cancers so insignificant that they probably would never have progressed or threatened the patients’ lives.

Although we at EuroMed believe in the importance of cancer screening for the breasts and other areas, we understand the concerns about invasive overtreatment. That’s why we have devoted our practice to alternative cancer therapies that leave a patient strong and healthy while destroying cancerous cells.

A  post on The New York Times‘ health blog recently delved into overtreatment and the notion that not all cancers are deadly. Although researchers suspect that some cancers will never harm the patient, there are practically no women out there who want to take the “wait and see” approach, the blog post says.

Surgery, radiation, and chemotherapy, while often effective at eliminating cancer, can also disrupt a patient’s immune system so profoundly that he or she will never be as healthy again. At EuroMed Foundation, we offer treatment options that can help destroy even the tiniest cancers without the unwanted side effects of overtreatment with more invasive options.

Our approach includes low-dose chemo through insulin potentiation therapy and an array of methods to support the immune system by removing toxins from the body and adding essential vitamins and minerals. This gentler approach has helped many patients with breast and other cancers overcome their diseases and go on to live stronger, healthier lives.

4 Responses to Avoiding Cancer ‘Overtreatment’

  • Helen Watt says:

    Hi Jim,

    Thank you for your post.

    We judge response to treatment in 3 ways:

    1. Clinical Picture: this involves our clinical evaluation of the patient each week including his/her input of how they feel. Specifically, we want to know if the symptoms that are related to their cancer getting better or worse? This tends to correlate quite well with their response to treatment.

    2. Periodic measurement of blood parameters (markers) that track their cancer’s growth. These include conventional markers in the blood for that particular cancer as well as other markers that may be typically elevated with other cancers but if high can serve to track their disease nevertheless. There are also more unconventional markers like inflammatory and new blood vessel formation markers that may help to indirectly track their cancer.

    3. Periodically repeating their scan (PET, CT, MRI, etc.) to quantify interval change.

    Using the above methods, we can get an accurate picture of their extent of disease and response to therapy.

  • Kevin Campbell says:

    Dear Dr. Watt,

    There is research that shows a metronomic approach to treatment is superior to a weekly treatment of chemotherapy during which a strong dose of medication is administered followed by a stage of convalescence for the patient before the next cycle of treatment. Unfortunately, it seems that a tumor is also able to recuperate between treatments while building up resistance to the treatment itself. Especially if the cancer cells succeed in triggering the formation of a new network of blood vessels by angiogenesis.

    On the other hand, it appears the continuous administration of medication or supplementation (metronomic procedure) on a daily basis, seems to have the effect of gradually reducing the number of cancer cells while simultaneously interfering with angiogenesis.

    In other words, it appears a weekly application of medication followed by 6 days of no treatment leads to short term reduction of tumors followed by eventual recurrence. On the other hand, consistent daily metronomic treatment seems to lead to full remission.

    My question is, if the above is true, how does one application of IPT weekly protect from the above intermittent concern allowing tumors to morph and recover during the non-treatment days between IPT application?

  • Helen Watt says:

    Hi Kevin, thanks for your post.

    In our experience, the development of resistance by the tumor is not only influenced by the timing of chemotherapy but the type, dose and number of chemotherapuetic agents as well. Because we are using very small dosages of each agent, we are able to include more drugs in a particular protocol, sometimes 5-7 in a protocol, and still not invoke significant side effects or toxicity. However, we have found that there is synergy between the agents, such that the effect is greater than if they were administered individually, sequentially. Our protocols are administered once or twice per week during the intense phase to drive the cancer back and understand the patient’s rate of response, which then determines their ongoing frequency of treatment.

    We have not seen significant resistance to our protocols, probably due to the number of chemotherapeutic drugs delivered in the protocols and the frequency of deliveries. In addition, we provide treatments to make the environment inhospitable for tumor growth, such as alkalinizing the patient’s chemistry, reducing copper/ceruloplasmin which play a role in angiogenesis, dietary restriction of carbohydrates which can feed cancer growth, etc.

Leave a Reply

Fields marked with * are required.

Free E-Book

on Alternative
Cancer Treatments

Download Now

Newsletter Sign-Up

EuroMed Foundation

34975 North North Valley Parkway,
Building 6, # 138
Phoenix, AZ 85086

Phone: (602) 404-0400
Fax: (602) 404-0403

Monday–Friday: 8 a.m.–5 p.m.

Contact Us

Terms of Use*
*By checking the box on the contact form, you agree to the Terms of Use listed here: Communications through our website or via email are not encrypted and are not necessarily secure. Use of the internet or email is for your convenience only, and by using them, you assume the risk of unauthorized use. By checking this box you hereby agree to hold EuroMed Foundation, its doctors and affiliates, harmless from any hacking or any other unauthorized use of your personal information by outside parties.